MedicaidPrior AuthMedium impact
Prior Authorization of Thalidomide and Derivatives – Pharmacy Services MAB 01-19-22
Pennsylvania Medicaid (DHS)·PA · Hematology, Oncology, Pharmacy·Prior Authorization
Effective date
Jan 1, 2020
We identified it
Jun 20, 2026
Summary
Pennsylvania Medicaid now requires prior authorization for all thalidomide and derivative medications, with specific requirements for specialist prescribing and medical necessity documentation. The policy establishes detailed clinical review guidelines including FDA-approved indications and quantity limits.
Action Required
For Pennsylvania Medicaid patients: Billing team must ensure prior authorization is obtained for all thalidomide and derivative prescriptions before dispensing. Verify prescriptions are written by or in consultation with hematologist/oncologist. Document FDA-approved indications, appropriate dosing, and therapeutic failure of preferred drugs when applicable. Claims will be denied without proper prior authorization.